Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hennessy

Showing results (51-60 of 249) with videos related to

Pageof 25
Sort By:
Expert Opinion on Investigational Drugs|December 4, 2003
DNA methylation in haematological malignancies: the role of decitabineBryan T Hennessy, Guillermo Garcia-Manero, Hagop M Kantarjian, et al.
Irish Medical Journal|May 1, 1995
Initial experience with percutaneous balloon mitral commissurotomyT Hennessy, J Galvin, C McKenna, et al.
Urology|November 1, 1981
Radiologic evaluation of anuric patient: systematized approachW T Hennessy, H M Pollack, M P Banner, et al.
Clinical Breast Cancer|February 14, 2008
Breast carcinoma with neuroendocrine differentiation and myocardial metastasesBryan T Hennessy, Michael Z Gilcrease, Edward Kim, et al.
Trends in Cancer|March 7, 2024
KMT2C and KMT2D aberrations in breast cancerEmily Tinsley, Philip Bredin, Sinead Toomey, et al.
Gastroenterology|August 1, 1993
Carbon dioxide retention and oxygen desaturation during gastrointestinal endoscopyM L Freeman, J T Hennessy, O W Cass, et al.
Expert Opinion on Investigational Drugs|December 19, 2017
PI3K inhibition to overcome endocrine resistance in breast cancerNiamh M Keegan, Jack P Gleeson, Bryan T Hennessy, et al.
Scientific Reports|October 8, 2025
Contrasting roles of KMT2C and KMT2D in breast cancerEmily Tinsley, Philip Bredin, Sinead Toomey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2005
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literatureB T Hennessy, A M Gauthier, L B Michaud, et al.
Cancer|November 27, 2004
New approaches in the treatment of myelofibrosisBryan T Hennessy, Deborah A Thomas, Francis J Giles, et al.
Pageof 25

Showing results (51-60 of 249) with videos related to

Sort By:
Pageof 25
Expert Opinion on Investigational Drugs|December 4, 2003
DNA methylation in haematological malignancies: the role of decitabineBryan T Hennessy, Guillermo Garcia-Manero, Hagop M Kantarjian, et al.
Irish Medical Journal|May 1, 1995
Initial experience with percutaneous balloon mitral commissurotomyT Hennessy, J Galvin, C McKenna, et al.
Urology|November 1, 1981
Radiologic evaluation of anuric patient: systematized approachW T Hennessy, H M Pollack, M P Banner, et al.
Clinical Breast Cancer|February 14, 2008
Breast carcinoma with neuroendocrine differentiation and myocardial metastasesBryan T Hennessy, Michael Z Gilcrease, Edward Kim, et al.
Trends in Cancer|March 7, 2024
KMT2C and KMT2D aberrations in breast cancerEmily Tinsley, Philip Bredin, Sinead Toomey, et al.
Gastroenterology|August 1, 1993
Carbon dioxide retention and oxygen desaturation during gastrointestinal endoscopyM L Freeman, J T Hennessy, O W Cass, et al.
Expert Opinion on Investigational Drugs|December 19, 2017
PI3K inhibition to overcome endocrine resistance in breast cancerNiamh M Keegan, Jack P Gleeson, Bryan T Hennessy, et al.
Scientific Reports|October 8, 2025
Contrasting roles of KMT2C and KMT2D in breast cancerEmily Tinsley, Philip Bredin, Sinead Toomey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2005
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literatureB T Hennessy, A M Gauthier, L B Michaud, et al.
Cancer|November 27, 2004
New approaches in the treatment of myelofibrosisBryan T Hennessy, Deborah A Thomas, Francis J Giles, et al.
Pageof 25